McKesson Co. (NYSE:MCK) Holdings Cut by Kintegral Advisory LLC

Kintegral Advisory LLC trimmed its stake in shares of McKesson Co. (NYSE:MCK) by 4.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,126 shares of the company’s stock after selling 52 shares during the quarter. Kintegral Advisory LLC’s holdings in McKesson were worth $643,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also made changes to their positions in the stock. MidAtlantic Capital Management Inc. acquired a new stake in McKesson in the third quarter worth $29,000. RPg Family Wealth Advisory LLC bought a new position in shares of McKesson during the third quarter worth about $31,000. Synergy Asset Management LLC acquired a new stake in shares of McKesson in the 4th quarter worth about $32,000. Crews Bank & Trust bought a new stake in McKesson in the 4th quarter valued at about $33,000. Finally, Creative Capital Management Investments LLC acquired a new position in McKesson during the 4th quarter valued at about $44,000. Institutional investors own 85.07% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have commented on MCK shares. Citigroup dropped their price target on shares of McKesson from $713.00 to $677.00 and set a “buy” rating on the stock in a research note on Friday, January 10th. Mizuho began coverage on McKesson in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $630.00 target price on the stock. Wells Fargo & Company boosted their price target on McKesson from $535.00 to $641.00 and gave the stock an “equal weight” rating in a research report on Friday, December 13th. StockNews.com lowered McKesson from a “strong-buy” rating to a “buy” rating in a report on Friday, February 14th. Finally, Morgan Stanley upped their price objective on shares of McKesson from $612.00 to $642.00 and gave the stock an “overweight” rating in a report on Tuesday, December 17th. Two analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $645.79.

Insider Activity at McKesson

In other news, EVP Leann B. Smith sold 579 shares of the business’s stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $572.79, for a total transaction of $331,645.41. Following the sale, the executive vice president now owns 864 shares in the company, valued at $494,890.56. The trade was a 40.12 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Brian S. Tyler sold 8,961 shares of the firm’s stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $600.66, for a total transaction of $5,382,514.26. Following the completion of the transaction, the chief executive officer now directly owns 69,625 shares of the company’s stock, valued at $41,820,952.50. This represents a 11.40 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 10,307 shares of company stock worth $6,177,790 in the last quarter. 0.11% of the stock is owned by company insiders.

McKesson Price Performance

Shares of MCK opened at $597.68 on Friday. McKesson Co. has a 12-month low of $464.42 and a 12-month high of $637.51. The stock has a market capitalization of $74.91 billion, a P/E ratio of 27.37, a P/E/G ratio of 1.29 and a beta of 0.52. The firm’s 50 day moving average is $589.02 and its 200-day moving average is $562.01.

McKesson (NYSE:MCK) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $8.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $8.60 by ($0.57). McKesson had a net margin of 0.82% and a negative return on equity of 181.26%. As a group, equities research analysts forecast that McKesson Co. will post 32.77 EPS for the current fiscal year.

McKesson Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 1st. Stockholders of record on Monday, March 3rd will be issued a dividend of $0.71 per share. This represents a $2.84 annualized dividend and a dividend yield of 0.48%. The ex-dividend date is Monday, March 3rd. McKesson’s dividend payout ratio is 13.00%.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.